Predictions
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.99
16.10.21
16.10.21
-
16.10.22
16.10.22
-
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.99
16.10.21
16.10.21
-
16.10.22
16.10.22
-
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.99
16.10.21
16.10.21
-
16.10.22
16.10.22
-
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€15.44
12.10.21
12.10.21
-
12.10.22
12.10.22
7.38%
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€2.60
04.10.21
04.10.21
-
04.10.22
04.10.22
-4.62%
16.10.21
16.10.21
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Valneva SE
Start price
Target price
Perf. (%)
€12.95
03.10.21
03.10.21
€20.00
03.10.22
03.10.22
15.83%
16.10.21
16.10.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
THC Biomed International Inc.
Start price
Target price
Perf. (%)
€0.070
17.04.20
17.04.20
-
04.11.21
04.11.21
-21.43%
14.10.21
14.10.21
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€12.50
30.07.21
30.07.21
€10.00
30.07.22
30.07.22
142.00%
13.10.21
13.10.21
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Flexion Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.40
29.09.21
29.09.21
€10.00
31.12.24
31.12.24
43.52%
11.10.21
11.10.21
Could be very worthwhile Investment >20% year
Poxel S.A.
Start price
Target price
Perf. (%)
€6.46
06.09.21
06.09.21
€5.00
06.09.22
06.09.22
-9.30%
07.10.21
07.10.21
Could be worthwhile Investment >10% per year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€3.50
14.09.21
14.09.21
-
14.09.22
14.09.22
-30.29%
05.10.21
05.10.21
Innovative
Formycon AG
Start price
Target price
Perf. (%)
€60.40
18.01.21
18.01.21
€80.00
18.01.22
18.01.22
-9.93%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.92
28.09.21
28.09.21
-
28.09.22
28.09.22
-6.85%
02.10.21
02.10.21
Could be worthwhile Investment >10% per year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€2.46
30.09.21
30.09.21
-
30.09.22
30.09.22
0.00%
02.10.21
02.10.21
Risky Investment
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€2.84
20.09.21
20.09.21
€4.00
20.09.22
20.09.22
-13.38%
02.10.21
02.10.21
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Innate Pharma
Start price
Target price
Perf. (%)
€6.61
18.09.21
18.09.21
€3.00
18.09.22
18.09.22
-22.01%
02.10.21
02.10.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.20
18.09.21
18.09.21
€2.00
18.09.22
18.09.22
-22.69%
02.10.21
02.10.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.55
20.09.21
20.09.21
€4.00
20.09.22
20.09.22
-13.87%
30.09.21
30.09.21
Good culture
Probably not worthwhile Investment
Below average Management
Little innovation
Editas Medicine Inc
Start price
Target price
Perf. (%)
€46.67
29.09.21
29.09.21
€35.00
31.10.22
31.10.22
-16.73%
29.09.21
29.09.21
Could be very worthwhile Investment >20% year
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.50
20.09.21
20.09.21
-
20.09.22
20.09.22
29.09%
21.09.21
21.09.21
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€4.48
14.09.21
14.09.21
-
14.09.22
14.09.22
-4.46%
19.09.21
19.09.21
Risky Investment
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€2.94
15.09.21
15.09.21
-
15.09.22
15.09.22
0.00%
19.09.21
19.09.21
Risky Investment
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.00
17.09.21
17.09.21
-
17.09.22
17.09.22
73.33%
19.09.21
19.09.21
Risky Investment
Editas Medicine Inc
Start price
Target price
Perf. (%)
€58.60
05.09.21
05.09.21
€70.00
05.09.22
05.09.22
-8.43%
18.09.21
18.09.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good rating
Very low/no dividend yield expected
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€4.42
04.09.21
04.09.21
€2.00
04.09.22
04.09.22
-33.48%
18.09.21
18.09.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected